Table 2 Distribution of the studied patients according to neuropathy assessment (n = 81)
| Â | No. | % |
|---|---|---|
VPT | ||
 < 25 (no neuropathy) | 60 | 74.1 |
 ≥ 25 (with neuropathy) | 21 | 25.9 |
 Mean ± SD | 19.83 ± 17.18 | |
Toronto score | ||
 No neuropathy (0–5) | 46 | 56.8 |
 Abnormal (6–19) | 35 | 43.2 |
  Mild (6–8) | 17 | 21.0 |
  Moderate (9–11) | 12 | 14.8 |
  Severe (12–19) | 6 | 7.4 |
 Mean ± SD | 4.94 ± 4.05 | |
Electrophysiological score (EPHAS) | ||
 No neuropathy | 14 | 17.3 |
 With neuropathy | 67 | 82.7 |
  Mild | 24 | 29.6 |
  Moderate | 33 | 40.7 |
  Severe | 10 | 12.3 |
 Mean ± SD | 23.26 ± 16.68 | |
Combined neuropathy score | ||
 No neuropathy | 14 | 17.3 |
 With neuropathy | 67 | 82.7 |
  Subclinical | 32 | 39.5 |
  Confirmed | 35 | 43.2 |